Cutter Capital Management, LP has filed its 13F form on February 14, 2025 for Q4 2024 where it was disclosed a total value porftolio of $244 Billion distributed in 21 stocks.

Among their holdings, we can observe that their the top five positions include companies like: Regeneron Pharmaceuticals, Inc. with a value of $22.4B, Johnson & Johnson with a value of $20.5B, Royalty Pharma PLC with a value of $19.5B, Abb Vie Inc. with a value of $18.1B, and Ultragenyx Pharmaceutical Inc. with a value of $17.1B.

Examining the 13F form we can see an decrease of $94.8B in the current position value, from $339B to 244B.

Cutter Capital Management, LP is based out at New York, NY

Below you can find more details about Cutter Capital Management, LP portfolio as well as his latest detailed transactions.

Portfolio value $244 Billion
Healthcare: $234 Billion

Stock Holdings Table

Stock Market Cap. Holding Value (Reported) # of Shares. Last Trade Trade History

Summary

  • Portfolio
  • No. of Stocks 21
  • Current Value $244 Billion
  • Prior Value $339 Billion
  • Filing
  • Period Q4 2024
  • Filing Date February 14, 2025
  • Form Type 13F-HR
  • Activity in Q4 2024
  • New Purchases 11 stocks
  • Additional Purchases 8 stocks
  • Sold out of 0 stocks
  • Reduced holdings in 2 stocks
Track This Portfolio

Track Cutter Capital Management, LP Portfolio

Follow Cutter Capital Management, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cutter Capital Management, LP, based on Form 13F filings with the SEC.

News

Stay updated on Cutter Capital Management, LP with notifications on news.